Developing a cross-industry digital compliance solution to revolutionise, democratise and streamline corporate due diligence for businesses

开发跨行业数字合规解决方案,以彻底改变、民主化和简化企业尽职调查

基本信息

  • 批准号:
    10008674
  • 负责人:
  • 金额:
    $ 30.9万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Feasibility Studies
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

Umazi is seeking to provide institutions with a cross-industry digital compliance solution that drastically reduces the complexity of compliance processes and improves efficiency by automating repeatable steps; using blockchain technology.Businesses that transact with each other often conduct due diligence on each other. This due diligence requires the verification of identity and credentials, making sure the organisation is legitimate and low-risk. Traditional due diligence processes are a cumbersome, manual, time-consuming exercise, and vary from organisation to organisation; making the process repetitive and costly.Umazi simplifies the due diligence process by leveraging distributed ledger technology to create a cryptographically secure corporate identity. The distributed ledger facilitates a secure and immutable way for the corporate to control and share their identity. The process becomes automated and streamlined. For financially regulated institutions this means better regulatory compliance, less regulatory, operational and reputational risk and improved KYC (corporate customers) and onboarding experience with customers. Alongside, significant back-office cost-savings.These benefits apply across all industries where it's important to verify the identity of your trading partner, such as large corporate partnerships and manufacturing outsource agreements; Umazi's solution is the same for all of them. The solution provides an exchange for a verified corporate identity, regardless of industry, country or language.Due diligence is a thorough appraisal of a business that a potential investor or buyer will undertake before engaging in a business deal. If you're the party doing the buying or investing, your lawyer will review the target company's assets & liabilities, structure, operations and business relationships.Financially regulated institutions (e.g. banks, insurers, law firms, real-estate, etc.) are required by law to conduct due diligence and risk assessments on clients. Tier-1 banks spend 15% of their costs/year on compliance. These institutions lose ~10% of customers due to onboarding friction. In 2012, the US Treasury's Financial Crimes Enforcement Network announced work on a new due diligence rule that would compel collection of ultimate beneficial ownership information. The publication of the Panama Papers in April 2016 accelerated the process, when the millions of leaked documents included in this trove detailed how offshore shell corporations have been used for money laundering, tax evasion and other illegal purposes. One month after they were released to the public, the US Treasury issued its Customer Due Diligence Rule. These events have spurred a global race for enhanced corporate due diligence that is sector-agnostic, cross-jurisdictional and independent of language.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

其他文献

吉治仁志 他: "トランスジェニックマウスによるTIMP-1の線維化促進機序"最新医学. 55. 1781-1787 (2000)
Hitoshi Yoshiji 等:“转基因小鼠中 TIMP-1 的促纤维化机制”现代医学 55. 1781-1787 (2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
LiDAR Implementations for Autonomous Vehicle Applications
  • DOI:
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
生命分子工学・海洋生命工学研究室
生物分子工程/海洋生物技术实验室
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
吉治仁志 他: "イラスト医学&サイエンスシリーズ血管の分子医学"羊土社(渋谷正史編). 125 (2000)
Hitoshi Yoshiji 等人:“血管医学与科学系列分子医学图解”Yodosha(涉谷正志编辑)125(2000)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Effect of manidipine hydrochloride,a calcium antagonist,on isoproterenol-induced left ventricular hypertrophy: "Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,K.,Teragaki,M.,Iwao,H.and Yoshikawa,J." Jpn Circ J. 62(1). 47-52 (1998)
钙拮抗剂盐酸马尼地平对异丙肾上腺素引起的左心室肥厚的影响:“Yoshiyama,M.,Takeuchi,K.,Kim,S.,Hanatani,A.,Omura,T.,Toda,I.,Akioka,
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:

的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('', 18)}}的其他基金

An implantable biosensor microsystem for real-time measurement of circulating biomarkers
用于实时测量循环生物标志物的植入式生物传感器微系统
  • 批准号:
    2901954
  • 财政年份:
    2028
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Exploiting the polysaccharide breakdown capacity of the human gut microbiome to develop environmentally sustainable dishwashing solutions
利用人类肠道微生物群的多糖分解能力来开发环境可持续的洗碗解决方案
  • 批准号:
    2896097
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
A Robot that Swims Through Granular Materials
可以在颗粒材料中游动的机器人
  • 批准号:
    2780268
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Likelihood and impact of severe space weather events on the resilience of nuclear power and safeguards monitoring.
严重空间天气事件对核电和保障监督的恢复力的可能性和影响。
  • 批准号:
    2908918
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Proton, alpha and gamma irradiation assisted stress corrosion cracking: understanding the fuel-stainless steel interface
质子、α 和 γ 辐照辅助应力腐蚀开裂:了解燃料-不锈钢界面
  • 批准号:
    2908693
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Field Assisted Sintering of Nuclear Fuel Simulants
核燃料模拟物的现场辅助烧结
  • 批准号:
    2908917
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Assessment of new fatigue capable titanium alloys for aerospace applications
评估用于航空航天应用的新型抗疲劳钛合金
  • 批准号:
    2879438
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Developing a 3D printed skin model using a Dextran - Collagen hydrogel to analyse the cellular and epigenetic effects of interleukin-17 inhibitors in
使用右旋糖酐-胶原蛋白水凝胶开发 3D 打印皮肤模型,以分析白细胞介素 17 抑制剂的细胞和表观遗传效应
  • 批准号:
    2890513
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
CDT year 1 so TBC in Oct 2024
CDT 第 1 年,预计 2024 年 10 月
  • 批准号:
    2879865
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship
Understanding the interplay between the gut microbiome, behavior and urbanisation in wild birds
了解野生鸟类肠道微生物组、行为和城市化之间的相互作用
  • 批准号:
    2876993
  • 财政年份:
    2027
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Studentship

相似国自然基金

胰岛素样生长信号介导的肺巨噬细胞和上皮细胞cross-tolk通过核自噬参与慢性气道炎症形成的机制研究
  • 批准号:
    JCZRYB202500229
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
  • 批准号:
    2025JJ80174
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
  • 批准号:
    JCZRYB202500379
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于破骨-成骨细胞Cross-Talk探讨内固定物存留对关节软骨退变的影响及补肾强骨治法的科学内涵
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
三痹汤激活线粒体自噬影响免疫细胞Cross talk延缓椎间盘退变的机制研究
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
PGK1乙酰化修饰介导癌细胞与TAMs间Cross-talk调控胆囊癌EMT的研究
  • 批准号:
    82373032
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
  • 批准号:
    82370171
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
生长激素受体通过脂肪酸介导的肝脏-脂肪Cross-talk影响脂质内稳态的研究
  • 批准号:
    82370866
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于“cross-β折叠”结构形成理论解析面筋蛋白淀粉样纤维的形成机制
  • 批准号:
    32372365
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目

相似海外基金

A Novel Sublingual Vaccine to Prevent Neisseria Gonorrhoeae Infection
预防淋病奈瑟菌感染的新型舌下疫苗
  • 批准号:
    10699065
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
The choice of partial versus full acquisition modes in cross-border deals and the contingent role of industries
跨境交易中部分收购与全部收购模式的选择以及行业的权变作用
  • 批准号:
    23K12544
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma
开发用于治疗胶质母细胞瘤的有效雌激素受体β激动剂
  • 批准号:
    10594832
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Multi-speed Ergonomic Wheelchair
多速人体工学轮椅
  • 批准号:
    10641410
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Racial and social contextual factors in relation to epigenome and bladder cancer outcome
与表观基因组和膀胱癌结果相关的种族和社会背景因素
  • 批准号:
    10762048
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
  • 批准号:
    10603636
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Development of a Longitudinal Observational Research Registry for the Study of Medicinal Cannabis Use and Health
开发药用大麻使用和健康研究的纵向观察研究登记册
  • 批准号:
    10741486
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Development of MecVax, a Cross Protective Subunit Vaccine for ETEC
开发 ETEC 交叉保护亚单位疫苗 MecVax
  • 批准号:
    10704838
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Project 1: Manipulating E-cigarette Nicotine to Promote Public Health
项目一:操控电子烟尼古丁促进公众健康
  • 批准号:
    10666067
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
Racial and social contextual factors in relation to epigenome and bladder cancer outcome.
与表观基因组和膀胱癌结果相关的种族和社会背景因素。
  • 批准号:
    10762268
  • 财政年份:
    2023
  • 资助金额:
    $ 30.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了